<DOC>
	<DOC>NCT00264615</DOC>
	<brief_summary>Pharmacokinetic (PK) study to characterize changes in serum concentrations in epilepsy patients when switching from LAMICTAL immediate-release to extended-release and vice versa.</brief_summary>
	<brief_title>Patients With Epilepsy Taking LAMICTAL Immediate-Release Who Switch To Extended-Release Formulation And Vice Versa</brief_title>
	<detailed_description />
	<mesh_term>Epilepsy</mesh_term>
	<mesh_term>Lamotrigine</mesh_term>
	<criteria>Inclusion criteria: Confident diagnosis of epilepsy. Currently on LAMICTAL and up to 2 concomitant AEDs (antiepileptic drugs). Females of childbearing potential cannot be on hormonal contraceptives or hormone replacement therapy.</criteria>
	<gender>All</gender>
	<minimum_age>13 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>once daily dosing</keyword>
	<keyword>seizure</keyword>
	<keyword>pharmacokinetics</keyword>
	<keyword>epilepsy</keyword>
</DOC>